Mastering the Safe Prescribing of Biologics and Small-Molecule Inhibitors in Dermatology: Tips and Pearls From Dr. Mona Shahriari
From the utility of annual TB testing for patients on biologics, the safety of vaccines during treatment, and the use of advanced therapeutics during pregnancy to monitoring protocols for patients on Janus kinase (JAK) and Tyrosine Kinase 2 (TYK2) inhibitors, Mona Shahriari, MD covers it all in this overview of her talk from the 2025 Diversity […]